November US FDA User Fee Calendar: Takeda On Tap; Small Molecules For Cancer

 
• By Bridget Silverman

Takeda hopes for good news on fruquintinib and TAK-755, while Bristol and SpringWorks share a goal date for their breakthrough-designated cancer treatments.

Thanksgiving dinner
Will sponsors enjoy a cornucopia of approvals this month? • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers